MedPath

北京春风药业有限公司

Ownership
-
Established
2010-02-09
Employees
-
Market Cap
-
Website
http://www.chunfengpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

27

NMPA:27

Drug Approvals

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H20194096
Approval Date
Sep 10, 2024
NMPA

Mecobalamin Tablets

Product Name
甲钴胺片
Approval Number
国药准字H20243780
Approval Date
May 21, 2024
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H20053399
Approval Date
May 10, 2024
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H20053396
Approval Date
May 10, 2024
NMPA

Captopril Tablets

Product Name
卡托普利片
Approval Number
国药准字H20053398
Approval Date
Apr 25, 2024
NMPA

Ranitidine Hydrochloride Capsules

Product Name
盐酸雷尼替丁胶囊
Approval Number
国药准字H20053397
Approval Date
Apr 25, 2024
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H20194013
Approval Date
Dec 26, 2023
NMPA

Ribavirin Nasal Drops

Product Name
利巴韦林滴鼻液
Approval Number
国药准字H20046321
Approval Date
Aug 5, 2022
NMPA

Roxithromycin Tablets

Product Name
罗红霉素片
Approval Number
国药准字H20065805
Approval Date
Aug 5, 2022
NMPA

Lomefloxacin Hydrochlocride Ear Drops

Product Name
盐酸洛美沙星滴耳液
Approval Number
国药准字H20055714
Approval Date
Aug 5, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.